Potassium Citrate (Biocomp Pharma, Inc.)
Welcome to the PulseAid listing for the Potassium Citrate drug offered from Biocomp Pharma, Inc.. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Biocomp Pharma, Inc. |
| NON-PROPRIETARY NAME: | potassium citrate |
| SUBSTANCE NAME: | POTASSIUM CITRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2013-12-23 |
| END MARKETING DATE: | 0000-00-00 |
Potassium Citrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Potassium Citrate from Biocomp Pharma, Inc. |
| LABELER NAME: | Biocomp Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(meq/1) |
| START MARKETING DATE: | 2013-12-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44523-415_b32fe71a-4a58-04a1-64d3-bc3cc4a895bf |
| PRODUCT NDC: | 44523-415 |
| APPLICATION NUMBER: | NDA019071 |
Other POTASSIUM CITRATE Pharmaceutical Manufacturers / Labelers:
